{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:16:43Z","timestamp":1788859003460,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["471819\/2013-1"],"award-info":[{"award-number":["471819\/2013-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["PPM-0515-15"],"award-info":[{"award-number":["PPM-0515-15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.vhri.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T17:35:24Z","timestamp":1628789724000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Health-Related Quality of Life in Psoriatic Arthritis: Findings and Implications"],"prefix":"10.1016","volume":"26","author":[{"given":"Felipe A.","family":"Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.R.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica B.R.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco A.","family":"Acurcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra M.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana M.","family":"Kakehasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Alvares-Teodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vhri.2021.06.003_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study [published correction appears in Arthritis Rheum. 2010;62(4):574]","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.003_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12016-012-8302-6","article-title":"Psoriatic arthritis: a critical review","volume":"44","author":"Dhir","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.vhri.2021.06.003_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.rbr.2013.11.001","article-title":"Analysis of the association of fatigue with clinical and psychological variables in a series of 371 Brazilian patients with rheumatoid arthritis","volume":"54","author":"Bianchi","year":"2014","journal-title":"Rev Bras Reumatol"},{"issue":"3","key":"10.1016\/j.vhri.2021.06.003_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/ker365","article-title":"Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone","volume":"51","author":"Rosen","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.vhri.2021.06.003_bib5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/bjd.12748","article-title":"Diagnosing and treating psoriatic arthritis: an update","volume":"170","author":"Boehncke","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.vhri.2021.06.003_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3899\/jrheum.120258","article-title":"Pharmacoeconomic issues in psoriatic arthritis","volume":"89","author":"Olivieri","year":"2012","journal-title":"J\u00a0Rheumatol Suppl"},{"issue":"6","key":"10.1016\/j.vhri.2021.06.003_bib7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","article-title":"A\u00a0patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative","volume":"73","author":"Gossec","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.vhri.2021.06.003_bib8","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.vhri.2021.06.003_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.vhri.2013.01.009","article-title":"Societal preferences for EQ-5D health states from a Brazilian population survey [published correction appears in Value Health Reg Issues. 2016;11:85-87]","volume":"2","author":"Viegas Andrade","year":"2013","journal-title":"Value Health Reg Issues"},{"issue":"11","key":"10.1016\/j.vhri.2021.06.003_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s40273-015-0295-6","article-title":"Can the EQ-5D detect meaningful change? A systematic review","volume":"33","author":"Payakachat","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.003_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.rdc.2016.01.002","article-title":"Patient-reported outcomes in psoriatic arthritis","volume":"42","author":"Orbai","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"10.1016\/j.vhri.2021.06.003_bib12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10067-014-2626-y","article-title":"Remission criteria and activity indices in psoriatic arthritis","volume":"33","author":"Acosta Felquer","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"suppl 2","key":"10.1016\/j.vhri.2021.06.003_bib13","doi-asserted-by":"crossref","first-page":"22s","DOI":"10.11606\/S1518-8787.2017051007134","article-title":"Health-related quality of life of patients of Brazilian primary health care [in Portuguese]","volume":"51","author":"Ascef","year":"2017","journal-title":"Rev Saude Publica"},{"issue":"4","key":"10.1016\/j.vhri.2021.06.003_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/21548331.2020.1785212","article-title":"Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff","volume":"48","author":"Alves de Oliveira Junior","year":"2020","journal-title":"Hosp Pract (1995)"},{"issue":"1","key":"10.1016\/j.vhri.2021.06.003_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s42358-019-0091-7","article-title":"Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long prath up to dispensation","volume":"59","author":"da Silva","year":"2019","journal-title":"Adv Rheumatol"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.003_bib16","doi-asserted-by":"crossref","DOI":"10.4155\/fsoa-2018-0101","article-title":"Medication persistence for psoriatic arthritis in a Brazilian real-world setting","volume":"5","author":"Ribeiro da Silva","year":"2019","journal-title":"Future Sci OA"},{"key":"10.1016\/j.vhri.2021.06.003_bib17","first-page":"1","article-title":"Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model [published online ahead of print, 2021]","author":"da Silva","year":"2021","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.003_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S0482-50042011000200005","article-title":"Brazilian Biologic Registry: BiobadaBrasil implementation process and preliminary results","volume":"51","author":"Titton","year":"2011","journal-title":"Rev Bras Reumatol"},{"issue":"8","key":"10.1016\/j.vhri.2021.06.003_bib20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/1744666X.2019.1631798","article-title":"Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations","volume":"15","author":"da Silva","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"10.1016\/j.vhri.2021.06.003_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2217\/cer-2018-0017","article-title":"Effectiveness and safety of anti-TNF in psoriatic arthritis patients in Brazil: a post-incorporation analysis","volume":"7","author":"da Silva","year":"2018","journal-title":"J\u00a0Comp Eff Res"},{"key":"10.1016\/j.vhri.2021.06.003_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-7-25","article-title":"The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people","volume":"7","author":"Salaffi","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.vhri.2021.06.003_bib23","first-page":"1","article-title":"Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model [published online ahead of print, 2020]","author":"Dos Santos","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"10.1016\/j.vhri.2021.06.003_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2217\/cer-2020-0275","article-title":"Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study","volume":"10","author":"K\u00f6mel Pimenta","year":"2021","journal-title":"J\u00a0Comp Eff Res"},{"issue":"12","key":"10.1016\/j.vhri.2021.06.003_bib25","first-page":"680","article-title":"The burden of psoriatic arthritis: a literature review from a global health systems perspective","volume":"35","author":"Lee","year":"2010","journal-title":"P\u00a0T"},{"issue":"3","key":"10.1016\/j.vhri.2021.06.003_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/14737167.2015.1003367","article-title":"Poorer functionality is related to better quality of life response following the use of biological drugs: 6-month outcomes in a prospective cohort from the public health system (Sistema \u00danico de Sa\u00fade), Minas Gerais, Brazil","volume":"15","author":"de Oliveira Junior","year":"2015","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"10.1016\/j.vhri.2021.06.003_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13075-020-02294-w","article-title":"Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates","volume":"22","author":"Haugeberg","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.vhri.2021.06.003_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","article-title":"Quality of life in psoriatic arthritis","volume":"14","author":"Gudu","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.vhri.2021.06.003_bib29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","article-title":"Comorbidities in psoriatic arthritis","volume":"41","author":"Husni","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.vhri.2021.06.003_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.reuma.2013.05.006","article-title":"Health-related quality of life in psoriatic arthritis patients in Spain","volume":"10","author":"Gratac\u00f3s","year":"2014","journal-title":"Reumatol Clin"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.003_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40744-020-00207-6","article-title":"Depression in psoriatic arthritis: dimensional aspects and link with systemic inflammation","volume":"7","author":"Mathew","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"1","key":"10.1016\/j.vhri.2021.06.003_bib32","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10279","article-title":"Comorbidities in patients with psoriatic arthritis","volume":"8","author":"Haddad","year":"2017","journal-title":"Rambam Maimonides Med J"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.003_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3899\/jrheum.141359","article-title":"Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study","volume":"43","author":"Haque","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.vhri.2021.06.003_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s42358-019-0086-4","article-title":"Self-reported disability in women with fibromyalgia from a tertiary care center","volume":"59","author":"Horta-Baas","year":"2019","journal-title":"Adv Rheumatol"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.003_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40744-020-00202-x","article-title":"The impact of comorbidity on patient-reported outcomes in psoriatic arthritis: a systematic literature review","volume":"7","author":"Ca\u00f1ete","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"6","key":"10.1016\/j.vhri.2021.06.003_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.rbr.2016.03.002","article-title":"Development of rheumatology training in Brazil: the option for a medical residency program","volume":"57","author":"Albuquerque","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"issue":"3","key":"10.1016\/j.vhri.2021.06.003_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1590\/S0482-50042013000300002","article-title":"Recommendations for the management and treatment of psoriatic arthritis","volume":"53","author":"Carneiro","year":"2013","journal-title":"Rev Bras Reumatol"},{"issue":"4","key":"10.1016\/j.vhri.2021.06.003_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/03009740903468982","article-title":"Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey","volume":"39","author":"Brodszky","year":"2010","journal-title":"Scand J Rheumatol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109921000935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109921000935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:13:00Z","timestamp":1761941580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109921000935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"alternative-id":["S2212109921000935"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2021.06.003","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-Related Quality of Life in Psoriatic Arthritis: Findings and Implications","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISPOR--The professional society for health economics and outcomes research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}